Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidation resistance protein 1 (OXR1) is a conserved antioxidant protein crucial for cellular defense against oxidative stress, particularly within the nervous system. OXR1 acts as a regulator of oxidative stress resistance by activating multiple protective responses including DNA repair, cell cycle arrest during oxidative damage, suppression of apoptosis, and detoxification of reactive oxygen species. It interacts with protein methyl transferase 5 (PRMT5) to modulate chromatin structure via histone methylation, impacting transcription of genes that increase oxidative stress resistance and cell viability. OXR1 is found in the cytoplasm and associated with mitochondria—especially its isoforms—where it influences mitochondrial morphology, further contributing to cell survival. Loss of OXR1 increases vulnerability to neurodegeneration and oxidative damage, while overexpression confers neuroprotection in both cellular and animal models. No approved drugs directly target OXR1, though its role makes it a candidate for antioxidant therapy development in diseases such as ALS, ataxia, and other oxidative stress-related neuropathologies.
Not directly applicable as no approved drugs are known; however, approaches would likely aim to upregulate OXR1, enhance its antioxidant activity, or modulate associated pathways (e.g., PRMT5 interaction for histone methylation and subsequent gene regulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidation resistance protein 1 (OXR1).